Patents by Inventor Jinao DUAN

Jinao DUAN has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230266339
    Abstract: Disclosed are a deer-derived specific peptide and a detection method therefor; by screening through a large number of experiments, a ratio of relative contents of two deer-derived peptides is determined, and a graph is drawn by using a proportion of a deer antler gelatin in a mixed gelatin as an abscissa and using a value of Apeptide 1/Apeptide 2 as an ordinate; the proportion of the deer antler gelatin is linear with Apeptide 1/Apeptide 2 as a standard curve equation to distinguish a deer hide gelatin from the deer antler gelatin; the method can be used for distinguishing the deer antler gelatin from the deer hide gelatin, and controlling the quality; a defect in the prior art that the deer antler gelatin and the deer hide gelatin are difficult to distinguish in appearance, and are also difficult to distinguish by using a specific peptide fragment, is solved.
    Type: Application
    Filed: November 26, 2020
    Publication date: August 24, 2023
    Inventors: Rui LIU, Shuo CAI, Mengtong JIANG, Kexuan ZHAO, Jinao DUAN
  • Publication number: 20210161929
    Abstract: Disclosed is an application of verbascoside in the preparation of drugs for preventing and treating type II diabetic nephropathy. The protective effect of verbascoside on type II diabetic nephropathy and the action mechanism thereof are also included in the invention. The results show that verbascoside may improve liver injuries caused by high glucose, and reduce levels of serum creatinine, urea nitrogen, microalbuminuria and blood lipid (total cholesterol and triglyceride), fasting blood sugar and serum insulin in spontaneous diabetic db/db mice, and significantly reduce expressions of TGF-?1 and its signal transduction protein Smad3 and Smad4 and ?-SMA in kidney tissues. Meanwhile, verbascoside may improve liver injuries caused by high glucose, and inhibit HK-2 proliferation and EMT formation.
    Type: Application
    Filed: February 11, 2021
    Publication date: June 3, 2021
    Inventors: Shulan SU, Jinao DUAN, Dawei QIAN, Yue ZHU, Hui YAN, Xinxin DAI
  • Publication number: 20190381082
    Abstract: Disclosed is an application of verbascoside in the preparation of drugs for preventing and treating type II diabetic nephropathy. The protective effect of verbascoside on type II diabetic nephropathy and the action mechanism thereof are also included in the invention. The results show that verbascoside may improve liver injuries caused by high glucose, and reduce levels of serum creatinine, urea nitrogen, microalbuminuria and blood lipid (total cholesterol and triglyceride), fasting blood sugar and serum insulin in spontaneous diabetic db/db mice, and significantly reduce expressions of TGF-?1 and its signal transduction protein Smad3 and Smad4 and ?-SMA in kidney tissues. Meanwhile, verbascoside may improve liver injuries caused by high glucose, and inhibit HK-2 proliferation and EMT formation.
    Type: Application
    Filed: December 29, 2018
    Publication date: December 19, 2019
    Inventors: Shulan SU, Jinao DUAN, Dawei QIAN, Yue ZHU, Hui YAN, Xinxin DAI